Robb L, Elwood N J, Elefanty A G, Köntgen F, Li R, Barnett L D, Begley C G
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia.
EMBO J. 1996 Aug 15;15(16):4123-9.
Homozygosity for a null mutation in the scl gene causes mid-gestational embryonic lethality in the mouse due to failure of development of primitive hematopoiesis. Whilst this observation established the role of the scl gene product in primitive hematopoiesis, the death of the scl null embryos precluded analysis of the role of scl in later hematopoietic development. To address this question, we created embryonic stem cell lines with a homozygous null mutation of the scl gene (scl-/-) and used these lines to derive chimeric mice. Analysis of the chimeric mice demonstrates that the scl-/- embryonic stem cells make a substantial contribution to all non-hematopoietic tissues but do not contribute to any hematopoietic lineage. These observations reveal a crucial role for the scl gene product in definitive hematopoiesis. In addition, in vitro differentiation assays with scl-/- embryonic stem cells showed that the scl gene product was also required for formation of hematopoietic cells in this system.
scl基因纯合无效突变会导致小鼠胚胎在妊娠中期死亡,原因是原始造血发育失败。虽然这一观察结果确定了scl基因产物在原始造血中的作用,但scl基因敲除胚胎的死亡使得无法分析scl在后期造血发育中的作用。为了解决这个问题,我们创建了具有scl基因纯合无效突变(scl-/-)的胚胎干细胞系,并利用这些细胞系培育出嵌合小鼠。对嵌合小鼠的分析表明,scl-/-胚胎干细胞对所有非造血组织有显著贡献,但对任何造血谱系均无贡献。这些观察结果揭示了scl基因产物在确定性造血中的关键作用。此外,对scl-/-胚胎干细胞进行的体外分化试验表明,该系统中造血细胞的形成也需要scl基因产物。